99% Savings - Buy Just @1 Rs X
Gestimax 250 Mg Injection is a prescription medicine that is available as a Injection. Primarily, it is used for the treatment of Premature Labor.
The correct dosage of Gestimax 250 Mg Injection depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Refer to the dosage section for a detailed discussion.
Apart from the aforementioned side effects, Gestimax 250 Mg Injection can also lead to other problems, which have been listed below. These side effects of Gestimax 250 Mg Injection are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Gestimax 250 Mg Injection's effect is Severe during pregnancy and Severe for lactating mothers. In addition, Gestimax 250 Mg Injection's effects on the liver, heart and kidney are discussed below in the Gestimax 250 Mg Injection related warnings section.
Gestimax 250 Mg Injection can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Gestimax 250 Mg Injection in conditions like Blood Clotting Disorders, Breast Cancer, Liver Disease. Other contraindications of Gestimax 250 Mg Injection have been discussed in the sections ahead.
Additionally, Gestimax 250 Mg Injection may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Gestimax 250 Mg Injection is considered not safe while driving, and is not addictive.
Gestimax 250 Mg Injection is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult(Female) |
|
Is the use of Gestimax 250 Mg Injection safe for pregnant women?
Gestimax has many dangerous side effects in pregnant women. If you are pregnant, do not consume Gestimax without medical advice.
Is the use of Gestimax 250 Mg Injection safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Gestimax. It should only be taken after medical advice.
What is the effect of Gestimax 250 Mg Injection on the Kidneys?
Gestimax may have mild side effects on the kidneys.
What is the effect of Gestimax 250 Mg Injection on the Liver?
You may experience side effects on your liver after taking Gestimax. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Gestimax 250 Mg Injection on the Heart?
Gestimax has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Gestimax 250 Mg Injection unless your doctor advises you to do so -
Is this Gestimax 250 Mg Injection habit forming or addictive?
No, there is no any evidence that Gestimax 250 Mg Injection is addictive.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Gestimax 250 Mg Injection. So it is best to avoid driving.
Is it safe?
Gestimax 250 Mg Injection should be used only after doctor's advice.
Is it able to treat mental disorders?
Gestimax 250 Mg Injection is unable to treat or cure mental disorders.
Interaction between Food and Gestimax 250 Mg Injection
Information is not available on the interaction of any foods with Gestimax 250 Mg Injection, due to a lack of research on this.
Interaction between Alcohol and Gestimax 250 Mg Injection
No research has been done on this till date. Therefore, it is not known what the effect of taking Gestimax 250 Mg Injection with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 663-664
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Makena® (hydroxyprogesterone caproate)